Keywords

• Ulipristal Acetate
• Ulipristal Acetate powder
• 99% Ulipristal Acetate

Quick Details

• ProName: cas 126784-99-4 99% purity Ulipristal...
• CasNo: 126784-99-4
• Molecular Formula: C15H22O5
• Appearance: white
• Application: Ulipristal acetate has also shown effi...
• DeliveryTime: 7-10 days
• PackAge: drum
• Port: Shanghai/Wuhan
• ProductionCapacity: 1000 Kilogram/Month
• Purity: 99
• Storage: room
• LimitNum: 1 Kilogram

Superiority

cas 126784-99-4  99% purity Ulipristal Acetate   

Product Name:    Ulipristal Acetate
CAS:    126784-99-4
MF:    C30H37NO4
MW:    475.62
EINECS:    682-170-1
 

Details

cas 126784-99-4  99% purity Ulipristal Acetate   

Product Name:    Ulipristal Acetate
CAS:    126784-99-4
MF:    C30H37NO4
MW:    475.62
EINECS:    682-170-1

Ulipristal acetate (UPA) is a selective progesterone receptor modulator. Attributing to its higher efficacy and a similar rate of side effects compared to levonorgestrel emergency contraception, it is now recommended as first line treatment for emergency contraception. Emergency contraception is defined as the use of drug or device after unprotected or under-protected intercourse to prevent an unwanted pregnancy.  

As progesterone promotes the growth of uterine fibroids, the blocking characteristic of ulipristal acetate can thereby be used to reduce the size of uterine fibroids. Ulipristal acetate has also shown efficacy with a significant reduction in uterine bleeding caused by uterine fibroids. The treatment of fibroids by ulipristal acetate should begin in the first week of a menstrual period.
Drugs or herbal products that induce enzymes, including CYP3A4, such as carbamazepine, phenytoin, rifampin, St. John's Wort, etc., may decrease the plasma concentrations of ulipristal acetate, and may decrease its effectiveness while CYP3A4 inhibitors such as itraconazole, ketoconazole, etc., may increase plasma concentrations of ulipristal acetate.